"The Mechanic" Cellular Energy Optimization Protocol

Your cells make energy the same way they always have. Mitochondria take in fuel, strip electrons off it, and use those electrons to drive a protein machine called the electron transport chain, which pumps protons across a membrane and uses that pressure to manufacture something called ATP, which is the actual currency your cells spend to do everything. Move a muscle. Fire a neuron. Repair a protein. All of it costs ATP.

That system works well when you are young. It starts breaking down in measurable ways as you age, and the breakdown happens in a specific sequence that points directly toward what you can do about it.

There are three distinct failure modes. The membrane that houses your electron transport chain gets damaged, which causes electrons to leak before they can do useful work. Senescent cells, which are cells that have stopped dividing but refuse to die, start consuming a molecule called NAD+ that your entire energy system depends on. And the machinery itself becomes less efficient at converting fuel into output. Understanding each of these separately is what makes the protocol logical instead of just a list of compounds to inject.

Start with the membrane problem because it is the most upstream failure in the chain.

Inside every mitochondrion there is an inner membrane folded into structures called cristae, and the entire electron transport chain sits inside those folds. For the chain to work, electrons have to move in an organized sequence from a carrier molecule called CoQ10, through a series of protein complexes, to their final destination at complex four. That organized movement is what pumps protons and builds ATP pressure. When the membrane is damaged, electrons escape the chain early, they react with oxygen before they are supposed to, and you get what is called reactive oxygen species, which are effectively molecular sparks that damage surrounding structures including the membrane itself. It is a self-reinforcing cycle of damage.

The membrane is held in shape by a lipid called cardiolipin, which is unique to mitochondria and acts as a kind of structural anchor for the protein complexes in the chain. When cardiolipin gets damaged or oxidized, the cristae collapse, the complexes lose their arrangement, and electron leakage goes up. A compound called SS-31 works by selectively binding to cardiolipin on the inner membrane, stabilizing its structure, and reducing that leakage. Research published in the Journal of the American Society of Nephrology showed that SS-31 re-energizes ischemic mitochondria specifically through this cardiolipin interaction, and work from Szeto and colleagues confirmed the mechanism reduces both electron leakage and reactive oxygen species production. The conservative dose in the protocol, 1 to 2 milligrams per day for four to eight weeks, is designed to stabilize the membrane before asking the system to perform harder.

CoQ10 becomes relevant here as well, because even with a stable membrane, the electron carriers have to be present in sufficient quantity. CoQ10 is the molecule that physically ferries electrons between complex one and complex three in the chain, and its levels decline significantly with age. Without enough of it, the chain slows regardless of membrane integrity. Five grams of creatine daily addresses a related but separate bottleneck: creatine helps regenerate ATP faster in tissues with high energy demand, particularly muscle and brain, buying time between the deeper mitochondrial repairs.

Now the second failure mode, NAD+ depletion, which is where most people have heard something but often have an incomplete picture.

NAD+ is not just a supplement trend. It is a cofactor that mitochondria require to run the first steps of electron extraction from fuel. Without adequate NAD+, the chain slows at its input end. The problem with the popular explanation is that it stops at "NAD+ declines with age" without explaining why, and that matters because the why determines what actually fixes it.

The mechanism runs through something called CD38, which is an enzyme that consumes NAD+. Research from Camacho-Pereira and colleagues in Cell Metabolism showed that CD38 activity increases two to three fold with age, and that mice bred without CD38 maintained their NAD+ levels across their entire lifespan. The question then is what drives CD38 up. Work published in Nature Metabolism in 2020 connected this to senescent cells directly. Senescent cells release inflammatory signals that cause nearby immune cells called macrophages to upregulate CD38. So the NAD+ depletion you experience with age is not just passive decay. It is being actively driven by the accumulation of senescent cells.

This is why the protocol targets senescent cells before prioritizing NAD+ supplementation.

FOXO4-DRI is a compound designed to trigger apoptosis, which is programmed cell death, specifically in senescent cells. The mechanism involves a protein called FOXO4 that senescent cells use to block p53, their own internal death signal. FOXO4-DRI disrupts that block, freeing p53 to do its job. Research from Baar and colleagues in Cell showed 11.73-fold selectivity for senescent cells over healthy cells. The off feeling that some people experience during the three-dose course, spaced every other day at 2 to 5 milligrams, reflects immune activity clearing the dying cells. That passes.

Epithalon at 500 micrograms to 1 milligram daily for 10 to 20 days runs alongside this phase. Research shows it induces expression of hTERT, which is the enzyme that extends telomeres, the protective caps on chromosomes that shorten with each cell division and contribute to the accumulation of senescent cells in the first place. One to two cycles per year is the protocol's approach to that upstream driver.

Once the membrane is stabilized and the senescent cell burden is reduced, the third phase is about pushing the repaired system to perform.

MOTS-c is a peptide that originates from inside the mitochondrial genome itself, and it activates something called AMPK, which is an enzyme that functions like a master switch for cellular energy sensing. When AMPK is active, cells become better at extracting energy from available fuel, more efficient at glucose uptake, and more responsive to metabolic signals. The 2015 Cell Metabolism study from Lee and colleagues showed MOTS-c prevented insulin resistance and diet-induced obesity in mice through exactly this AMPK activation pathway. At 5 to 15 milligrams per week split into three injections, you are asking newly repaired mitochondria to operate closer to their actual capacity.

On NAD+ specifically: the reason niacin is the recommendation over NMN or NR comes down to gut metabolism. Research published in Science Advances in 2025 confirmed that most oral NMN and NR is converted to niacin-pathway metabolites in the gut before absorption anyway. The gut bacteria essentially deamidate nicotinamide to nicotinic acid before it reaches your bloodstream. You are largely paying a premium to arrive at the same destination. Niacin at a fraction of the cost covers the same ground, and NAMPT, which is the enzyme your cells use to recycle NAD+, increases by 127% with exercise training alone according to work in the American Journal of Physiology.

The optional addition of injectable L-carnitine at 200 to 500 milligrams three to five times per week addresses a separate transport step. Long-chain fatty acids cannot enter the mitochondrial matrix on their own. L-carnitine is the only molecule that carries them across the inner membrane for the process called beta-oxidation, where they are broken down into fuel. If your energy needs are high or fat burning is a priority, this is where it plugs in.

The whole protocol is sequenced the way it is because the problems are sequential. You cannot meaningfully optimize a leaking machine. You cannot restore NAD+ while the senescent cells driving its depletion are still active. And you cannot push a damaged mitochondrial network harder without first giving it the structural integrity to handle the demand.

Training, sleep, and nutrition set the baseline signal. The protocol amplifies what those signals are asking for. In the absence of that signal, there is nothing to amplify.

---

References

1. Birk AV, Liu S, Soong Y, et al. The Mitochondrial-Targeted Compound SS-31 Re-Energizes Ischemic Mitochondria by Interacting with Cardiolipin. Journal of the American Society of Nephrology. 2013;248:1250-1261. Finding: SS-31 selectively binds cardiolipin on the inner mitochondrial membrane, stabilizing cristae structure. Source
2. Szeto HH. First-in-class cardiolipin-protective compound as a therapeutic agent to restore mitochondrial bioenergetics. British Journal of Pharmacology. 2014;1718:2029-2050. Finding: SS-31 binds cardiolipin, stabilizes mitochondrial membrane structure, and reduces electron leakage and ROS production. Source
3. Baar MP, Brandt RMC, Putavet DA, et al. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017;1691:132-147. Finding: FOXO4-DRI disrupts FOXO4-p53 interaction in senescent cells, freeing p53 to trigger apoptosis. 11.73-fold selectivity for senescent vs healthy cells. Source
4. Camacho-Pereira J, Tarrago MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism. Cell Metabolism. 2016;236:1127-1139. Finding: CD38 activity increases 2-3 fold with age. CD38 knockout mice maintained NAD+ levels at all ages. Source
5. Covarrubias AJ, Kale A, Perrone R, et al. Senescent cells promote tissue NAD+ decline during ageing via the activation of CD38+ macrophages. Nature Metabolism. 2020;211:1265-1283. Finding: Senescent cell SASP cytokines induce macrophages to upregulate CD38, establishing the causal chain from senescence to NAD+ decline. Source
6. Khavinson VKh, Bondarev IE, Butyugov AA. Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Bulletin of Experimental Biology and Medicine. 2003;1356:590-592. Finding: Epithalon induced hTERT expression, telomerase activity, and telomere elongation in human fibroblasts. Source
7. Goncharova ND, Vengerin AA, Khavinson VKh, Lapin BA. Pineal peptides restore the age-related disturbances in hormonal functions of the pineal gland and the pancreas. Experimental Gerontology. 2005;401-2:51-57. Finding: Epithalamin at 5mg/day and synthetic Epithalon at 10mcg/day achieved equivalent melatonin restoration in aged monkeys, demonstrating 500-fold potency difference. Source
8. Lee C, Zeng J, Drew BG, et al. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistance. Cell Metabolism. 2015;213:443-454. Finding: MOTS-c activates AMPK via inhibition of the folate cycle. Prevented insulin resistance and diet-induced obesity. Source
9. Shats I, Williams JG, Liu J, et al. Bacteria Boost Mammalian Host NAD Metabolism by Engaging the Deamidated Biosynthesis Pathway. Cell Metabolism. 2020;313:564-579. Finding: Gut bacteria deamidate nicotinamide to nicotinic acid niacin, confirming NMN/NR undergo gut conversion before absorption. Source
10. Kim LJ, et al. Nicotinamide riboside and nicotinamide mononucleotide facilitate NAD+ synthesis via enterohepatic circulation. Science Advances. 2025. Finding: Most oral NMN and NR is converted to niacin-pathway metabolites in the gut before absorption. Source
11. Costford SR, Bajpeyi S, Pasarica M, et al. Skeletal muscle NAMPT is induced by exercise in humans. American Journal of Physiology - Endocrinology and Metabolism. 2010;2981:E117-E126. Finding: NAMPT protein increased 127% in sedentary subjects after exercise training. Source
12. Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochimica et Biophysica Acta. 2016;186310:2422-2435. Finding: L-carnitine is the sole molecule carrying long-chain fatty acids across the inner mitochondrial membrane for beta-oxidation. Source
13. Banerjee R, Purhonen J, Bhardwaj R, Bhargava A, Kallijarvi J. The mitochondrial coenzyme Q junction and complex III. The FEBS Journal. 2022;28922:6936-6958. Finding: CoQ serves as the mobile electron carrier between Complex I/II and Complex III. Source

---

Join the free community:
Men: Iron Forge Brotherhood
Women: Powerhouse Fitness